ERBB2 and breast cancer: Pertuzumab has been often used in conjunction with other HER2-targeted drugs and chemotherapy such as trastuzumab, trastuzumab emtansine (T-DM1), atezolizumab, docetaxel, and taxane, significantly improving PFS or delaying brain metastases in patients with BC [56].